ZIM Laboratories

ZIM Laboratories EBIT

The EBIT of ZIM Laboratories (ZIMLAB.NS) as of Oct 24, 2026 is 188.70 M INR. In the previous year, EBIT was 200.46 M INR — a change of -5.87% (lower).

EBIT

188.70 MINR

YoY

-5.87%

Last updated:

In 2026, ZIM Laboratories's EBIT was 188.70 M INR, a -5.87% increase from the 200.46 M INR EBIT recorded in the previous year.

The ZIM Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
315.57 M INR
Jan 1, 2020
102.01 M INR
Jan 1, 2021
247.24 M INR
Jan 1, 2022
224.56 M INR
Jan 1, 2023
363.21 M INR
Jan 1, 2024
304.37 M INR
Jan 1, 2025
200.46 M INR
Jan 1, 2026
188.70 M INR
The ZIM Laboratories EBIT history
YEAREBITYoY
188.70 MINR-5.87%
200.46 MINR-34.14%
304.37 MINR-16.20%
363.21 MINR+61.74%
224.56 MINR-9.17%
247.24 MINR+142.37%
102.01 MINR-67.68%
315.57 MINR+15.04%
274.32 MINR+15.23%
238.05 MINR+9.50%
217.40 MINR+47.59%
147.30 MINR-74.58%
579.48 MINR+145.31%
236.22 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ZIM Laboratories Revenue

ZIM Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
3.26 B INR
315.57 M INR
153.42 M INR
Jan 1, 2020
2.61 B INR
102.01 M INR
32.97 M INR
Jan 1, 2021
3.07 B INR
247.24 M INR
73.18 M INR
Jan 1, 2022
3.31 B INR
224.56 M INR
145.50 M INR
Jan 1, 2023
3.99 B INR
363.21 M INR
244.35 M INR
Jan 1, 2024
3.68 B INR
304.37 M INR
172.46 M INR
Jan 1, 2025
3.74 B INR
200.46 M INR
121.65 M INR
Jan 1, 2026
3.69 B INR
188.70 M INR
58.38 M INR

ZIM Laboratories Margins

ZIM Laboratories stock margins

The ZIM Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ZIM Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ZIM Laboratories.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
50.90 %
9.67 %
4.70 %
Jan 1, 2020
44.60 %
3.91 %
1.26 %
Jan 1, 2021
48.18 %
8.04 %
2.38 %
Jan 1, 2022
50.50 %
6.79 %
4.40 %
Jan 1, 2023
22.68 %
9.11 %
6.13 %
Jan 1, 2024
50.60 %
8.28 %
4.69 %
Jan 1, 2025
19.51 %
5.36 %
3.25 %
Jan 1, 2026
16.69 %
5.11 %
1.58 %

ZIM Laboratories Stock analysis

What does ZIM Laboratories do? Zim Laboratories Ltd. develops, manufactures, and supplies oral solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) across therapeutic segments including central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology, and vitamins, minerals, and dietary supplements. The company's technological capabilities focus on drug release modification, solubility and stability enhancement, taste masking, and dosage form transformation. Its product offerings include finished formulations such as tablets, capsules, oral thin films, granules, pellets, taste-masked powders, and dry suspensions, alongside pre-formulation intermediates. The firm generates revenue through the supply of these pharmaceutical products to healthcare providers and distributors within the Indian market. The company's delivery solutions encompass product conceptualization, development, registration filing, manufacturing, and supply, targeting various therapeutic segments. Its differentiated generic formulations cater to specific medical needs, with a focus on innovation in drug delivery systems. Zim Laboratories Ltd. serves the Indian pharmaceutical market, supplying both finished products and pre-formulation intermediates to meet the demands of healthcare institutions and retail pharmacies. Zim Laboratories Ltd. operates as a pharmaceutical company based in Nagpur, Maharashtra, with 525 full-time employees. It develops and manufactures generic pharmaceutical products including oral solid dosage forms and pre-formulation intermediates. The company's revenue streams come from the sale of these products to customers in the healthcare sector, particularly within the Indian market, leveraging its technological capabilities in drug formulation and delivery. ZIM Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing ZIM Laboratories's EBIT

ZIM Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of ZIM Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

ZIM Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in ZIM Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about ZIM Laboratories stock

EBIT of ZIM Laboratories is 188.70 M INR in 2026.

EBIT of ZIM Laboratories changed from 200.46 M INR to 188.70 M INR, representing a -5.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT ZIM Laboratories since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's ZIM Laboratories historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ZIM Laboratories

All Key Metrics — ZIM Laboratories